Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock—Adaptive Clinical Trial

Roger Lewis, Scott Berry, Steven M. Opal et al.|Annals of the American Thoracic Society|2018

Cited by 44